- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ICL670
Total 38 results
-
Novartis PharmaceuticalsCompletedTransfusional Hemosiderosis | Chronic AnemiaJapan, Turkey, Spain, Poland, Singapore
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Transfusion Dependent Iron OverloadGermany
-
Novartis PharmaceuticalsCompletedChronic Iron Overload Due to Transfusion-dependant AnemiasItaly, Austria, Thailand, Spain, Germany, Mexico, Malaysia, Greece, United Kingdom, France, Saudi Arabia, United Arab Emirates, Lebanon, Russian Federation, United States, Argentina
-
PfizerTerminatedHypertension, PulmonaryJapan
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminatedMyelodysplastic Syndrome | Transfusional Iron OverloadSpain, France, Italy, South Africa
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndrome | ThalassemiaRussian Federation
-
Novartis PharmaceuticalsCompletedTransfusional Iron Overload | β-thalassemiaItaly
-
Novartis PharmaceuticalsCompletedTransfusional Iron OverloadUnited States, Greece, Italy
-
Novartis PharmaceuticalsCompletedAnemia | HemosiderosisUnited States, Germany, Belgium, United Kingdom, Italy, Canada, France
-
Novartis PharmaceuticalsCompletedIron OverloadUnited Kingdom, Italy, Oman, United Arab Emirates, Lebanon, Thailand, Egypt
-
Novartis PharmaceuticalsCompletedTransfusional Iron OverloadItaly
-
Novartis PharmaceuticalsCompletedTransfusion-dependent Iron OverloadEgypt, Greece, Hong Kong, Taiwan, Germany, United Kingdom, Belgium, Italy, Spain, France, Israel, Korea, Republic of, Turkey, China, Australia, Denmark, Austria, Switzerland, Netherlands, South Africa, Lebanon, Malaysia, Thailand
-
Novartis PharmaceuticalsCompletedTransfusional Iron Overload | β-thalassemia Major | Pediatric Rare AnemiaItaly, France
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedSickle Cell DiseaseUnited States, Italy, United Kingdom, France, Canada
-
Novartis PharmaceuticalsCompletedIron Overload | Hereditary HemochromatosisUnited States, Germany, Italy, Australia, Canada, France
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Beta-ThalassemiaHungary
-
Novartis PharmaceuticalsCompletedTransfusional HemosiderosisEgypt, Spain, United Kingdom, Jordan
-
Novartis PharmaceuticalsCompletedNon-transfusion Dependent ThalassemiaThailand, Turkey, Italy, Greece, China, United Kingdom, Lebanon, Tunisia
-
City of Hope Medical CenterTerminatedPrimary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Iron Overload | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedIron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia MajorTurkey
-
Crolll GmbhUniversity of Magdeburg; Estimate, GmbHCompletedNon-alcoholic Steatohepatitis | Increased Iron Storage / Disturbed DistributionGermany
-
Novartis PharmaceuticalsCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHigh Risk MDS or AML PatientsUnited States
-
NovartisCompletedMyelodysplastic Syndromes | Hemoglobinopathies | Diamond-Blackfan Anemia | Transfusional Iron Overload | Other Inherited or Acquired Anaemia | MPD Syndrome | Other Rare AnaemiasAustralia
-
Novartis PharmaceuticalsCompletedBeta-ThalassemiaUnited States
-
Novartis PharmaceuticalsCompletedHereditary HemochromatosisBelgium, France, Russian Federation, Romania, Slovakia, Spain, Switzerland
-
Novartis PharmaceuticalsCompletedTransfusion-dependent AnemiaEgypt, Hungary, Turkey, United States, Bulgaria, Italy, Belgium, Russian Federation, Philippines, France, Malaysia, India, Oman, Panama, Lebanon, Thailand, Tunisia
-
Novartis PharmaceuticalsCompletedAnemia, Sickle CellUnited States
-
Weill Medical College of Cornell UniversityUnknownThalassemiaUnited States
-
Novartis PharmaceuticalsCompletedIron Overload | Sickle Cell Disease | Hemolytic AnemiaUnited States, Canada
-
Novartis PharmaceuticalsCompletedMyelodysplastic SyndromesChina, Hong Kong, Switzerland, United Kingdom, Italy, Thailand, Bulgaria, Greece, Russian Federation, Canada, Mexico, Australia, Denmark, Malaysia, New Zealand, United States
-
Boston Children's HospitalNovartisCompletedSickle Cell Disease | Thalassemia Major | Transfusion-dependent HemachromatosisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma and other conditionsUnited States
-
Novartis PharmaceuticalsTerminatedAplastic AnemiaRussian Federation
-
Novartis PharmaceuticalsTerminatedCardiac Iron Overload | Transfusion-dependent β-thalassemia PatientsGreece
-
Novartis PharmaceuticalsCompletedIron Overload | Myelodysplastic SyndromeUnited States, Canada